Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events patient preferences considered first time fda decision approve first kind obesity
RWE Studies Using Primary Data Collection To meet the requirements of risk management programs, inform drug development and post-approval strategies, or answer epidemiologic questions, we can help you design and implement real-world evidence research …
… Congress. Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among …
… continues to pose significant challenges for Swedish decision-makers – due often to high costs and limited … the rarity of the condition. However, in 2016, TLV for the first time accepted a higher cost per quality-adjusted life-year …
… Treatment Trends for Chronic Lymphocytic Leukemia Time trends in frontline systemic therapy utilization for … Our study includes nearly 1400 patients receiving their first treatment during July 2012 to June 2016. The … during the study period. In contrast, the use of a first-in-class Bruton’s tyrosine kinase inhibitor, ibrutinib, …
… Improved voting questions and structure Enhancements in patient engagement program to promote diversity in patients … trial design and demographic information ahead of first availability of the study outcomes Strengthen trial … key scenarios reflecting changes in drug pricing over time. For example, ICER proposes that the price of small …
… the reach of your research and improve shared healthcare decision making. From patients and caregivers to busy medical … benefits of disseminating PLS to achieve meaningful patient involvement in drug or device development, … reimbursement. PLS as a resource for improved physician-patient shared decision-making in clinical practice. What to …
… as a speaker in the DIA 2022 session, Fit-for-Purpose Patient Preference Studies: Emerging Recommendations from IMI … by those involved in preference research, including how decision-makers and patient research partners were involved. Alicia Gilsenan, …
… therapies, because the IRA clock starts with the first approval. They might also do so because of the …
… of RTI Health Solutions have published a study in The Patient – Patient-Centered Outcomes Research that explores this subject … Respondents’ sociodemographic characteristics Response time and attention Respondents’ self-reported understanding …
… to support your asset. You can develop insights into the patient experience by linking patient-reported outcomes with clinician-reported outcomes. … to examine if and why treatment responses vary over time and across disease subtypes. Or you can determine if …